Lipophilicity in Drug Development: Too Much or Not Enough?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AAPS Journal

• Publication date

  2016-07-08

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1208/s12248-016-9947-5PMID 27393481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computational prediction of formulation strategies for beyond-rule-of-5 compounds.

  2016cited by this paper
• Molecular inflation, attrition and the rule of five.

  2016cited by this paper
• 50years of oral lipid-based formulations: Provenance, progress and future perspectives.

  2016cited by this paper
• Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions.

  2016cited by this paper
• Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.

  2015cited by this paper
• Profiling the Role of Deacylation-Reacylation in the Lymphatic Transport of a Triglyceride-Mimetic Prodrug

  2015cited by this paper
• From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity

  2015cited by this paper
• Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.

  2014cited by this paper
• The Discovery of Navitoclax, a Bcl-2 Family Inhibitor

  2012cited by this paper
• The influence of the 'organizational factor' on compound quality in drug discovery

  2011cited by this paper
• Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity.

  2011cited by this paper
• Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.

  2010cited by this paper
• Molecular characteristics for solid-state limited solubility.

  2008cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Estimation of the aqueous solubility I: application to organic nonelectrolytes.

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper

• Hemisynthesis of lupeol and betulin derivatives and their in vitro antimalarial activity against Plasmodium falciparum FCR3.

  2025cites this paper
• On the tumor cell growth limiting potential of newly synthesized acridine-1,8-dione derivatives.

  2025cites this paper
• Design, Synthesis, and In‐Vitro Evaluation of Novel Butanoic Acid Derivatives as Potential Soluble Epoxide Hydrolase Inhibitors

  2024cites this paper
• Ferrocene-Bisphosphonates Hybrid Drug Molecules: In Vitro Antibacterial and Antifungal, In Silico ADME, Drug-Likeness, and Molecular Docking Studies

  2024cites this paper
• Odor Discrimination by Lipid Membranes

  2023cites this paper
• Advancing Algorithmic Drug Product Development: Recommendations for Machine Learning Approaches in Drug Formulation.

  2023cites this paper
• Drug Delivery Across the Blood-Brain Barrier for the Treatment of Pediatric Brain Tumors - An Update.

  2022cites this paper
• Spray Drying as an Effective Method in the Development of Solid Self-Emulsifying Drug Delivery Systems.

  2022cites this paper
• Trends in small molecule drug properties: a developability molecule assessment perspective.

  2022cites this paper
• Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products

  2021cites this paper
• Acacetin and pinostrobin as a promising inhibitor of cancer-associated protein kinases.

  2021cites this paper
• Descubrimiento de fármacos basado en imagenología de células vivas

  2020cites this paper
• New Insights into Using Lipid Based Suspensions for ‘Brick Dust’ Molecules: Case Study of Nilotinib

  2019cites this paper
• A Strategy to Find Novel Candidate DKAs Inhibitors Using Modified QSAR Model with Favorable Druggability Properties

  2019cites this paper
• Comparative study of inorganic, boron-rich cluster and organic, phenyl adenosine modifications: synthesis and properties.

  2019cites this paper
• Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes.

  2018cites this paper
• Novel natural product therapeutics targeting both inflammation and cancer.

  2017cites this paper